Back

Kidney single-cell transcriptomes uncover SGLT2i-induced metabolic reprogramming via restoring glycolysis and fatty acid oxidation

Shi, Y.; Bhalla, V.

2023-11-02 genetics
10.1101/2023.10.31.564836 bioRxiv
Show abstract

Approximately 40% of individuals with chronic kidney disease have type 2 diabetes mellitus, and diabetic kidney disease is the leading cause of end-stage kidney disease worldwide. Inhibitors of sodium-glucose cotransporter 2 (SGLT2) have been demonstrated to be effective in glucose control, improving cardiovascular outcomes and the progression of kidney disease. However, the protective role of SGLT2 inhibition on kidney metabolism is not fully understood. To explore these mechanisms further, we conducted analysis of publicly available single-cell RNA sequencing data of db/db mice treated with an SGLT2 inhibitor(dapagliflozin) and accompanying controls. We found that proximal tubule cells exhibited impaired glycolysis and high fatty acid oxidation in diabetes compared with control mice. SGLT2 inhibition reversed this metabolic dysfunction by reducing glycolysis and its substrate accumulation. SGLT2 inhibition also upregulates high fatty oxidation without increasing the uptake of fatty acids and elongation, along with low lipotoxicity. Surprisingly, both SGLT2(+) and SGLT2(-) cells show gene consistent changes in expression of metabolic genes, consistent with a non-cell autonomous effect of dapagliflozin treatment. This study demonstrates the protective role of SGLT2 inhibition via restoring metabolic dysfunction.

Matching journals

The top 13 journals account for 50% of the predicted probability mass.

1
eLife
● 5828 papers in training set
Top 10%
10.0%
Similar papers in this journal
2
PLOS ONE
● 5266 papers in training set
Top 28%
5.3%
Similar papers in this journal
3
Scientific Reports
○ 3612 papers in training set
Top 18%
4.9%
Similar papers in this journal
4
International Journal of Molecular Sciences
○ 494 papers in training set
Top 2%
4.1%
5
Human Molecular Genetics
◐ 141 papers in training set
Top 0.5%
4.1%
Similar papers in this journal
6
Diabetologia
○ 44 papers in training set
Top 0.2%
4.1%
7
iScience
○ 1154 papers in training set
Top 4%
4.1%
Similar papers in this journal
8
The FASEB Journal
○ 194 papers in training set
Top 1%
3.3%
9
Frontiers in Genetics
○ 230 papers in training set
Top 1%
2.8%
10
Kidney360
○ 22 papers in training set
Top 0.2%
2.8%
11
Physiological Reports
○ 40 papers in training set
Top 0.4%
2.2%
12
Cells
○ 249 papers in training set
Top 2%
2.2%
13
PLOS Genetics
● 862 papers in training set
Top 6%
2.2%
50% of probability mass above
14
Theranostics
● 37 papers in training set
Top 0.4%
2.0%
15
Journal of Biological Chemistry
○ 690 papers in training set
Top 5%
1.8%
16
Cell Death & Disease
147 papers in training set
Top 2%
1.8%
17
JCI Insight
● 277 papers in training set
Top 5%
1.5%
18
Molecular Therapy - Nucleic Acids
○ 25 papers in training set
Top 0.4%
1.4%
19
Frontiers in Endocrinology
○ 58 papers in training set
Top 1.0%
1.2%
20
BMC Genomics
○ 406 papers in training set
Top 6%
1.1%
21
Journal of Biomedical Science
○ 17 papers in training set
Top 0.2%
1.1%
22
Journal of the American Society of Nephrology
○ 56 papers in training set
Top 0.6%
1.0%
23
eBioMedicine
○ 183 papers in training set
Top 5%
1.0%
24
Diabetes
● 56 papers in training set
Top 0.8%
1.0%
25
Communications Biology
○ 993 papers in training set
Top 28%
0.9%
26
Journal of Virology
● 499 papers in training set
Top 3%
0.9%
27
Nature Communications
○ 5641 papers in training set
Top 55%
0.9%
28
Experimental & Molecular Medicine
○ 14 papers in training set
Top 0.1%
0.9%
29
Aging
○ 75 papers in training set
Top 2%
0.9%
30
Genomics, Proteomics & Bioinformatics
188 papers in training set
Top 2%
0.7%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.